NACDS RxIMPACT rallies senate support for action on DIR fees
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) RxIMPACT grassroots advocacy program has mobilized to support a U.S. Senate initiative urging action by U.S.
Pharmacy
CVS donates more than $330,000 to combat opioid abuse in California
CVS Health announced today that the CVS Health Foundation will award $330,000 in grants to community health centers in California focused on increasing access to opioid addiction treatment and recovery services.
Cure Pharmaceutical to acquire cannabinoid-based pipeline from Therapix Biosciences
OXNARD, Calif. – Cure Pharmaceutical announced that it has signed a term sheet with Therapix Biosciences, a specialty, clinical-stage pharmaceutical company developing cannabinoid-based treatments, to acquire the non-pain assets of Therapix, subject to the completion of the related conditions.
CVS Health expands initiatives to fight opioid abuse in Maryland
As part of CVS Health’s national commitment to address and prevent opioid abuse and misuse, the company has installed 19 safe medication disposal units in CVS Pharmacy locations across Maryland and the CVS Health Foundation has provided $85,000 to Total Health Care in Baltimore, a community health c
Dr. Reddy’s rolls out generic of Plaquenil
Dr. Reddy’s Laboratories announced the launch of hydroxychloroquine sulfate tablets USP, 200 mg, a therapeutic equivalent generic version of Plaquenil (hydroxychloroquine sulfate) tablets, in the U.S. market, approved by the U.S. Food and Drug Administration. The Plaquenil brand and generic had U.S.
Report shows benefits of expanded pharmacy technician
A new report makes a compelling, evidence-based case for expanding the role of pharmacy technicians to enhance pharmacist-provided patient care.
Avella’s use of AdhereTech improves adherence
Avella Specialty Pharmacy’s Use of AdhereTech smart pill bottles improved adherence and generated one to two additional fills per patient per year across multiple specialty medications and diseases The specialty pharmacy uses the smart bottles for five specialty medications, in programs with four di
Teva launches of a generic version of Uceris in the United States
Teva Pharmaceutical Industries Ltd., today announced the launch of a generic version of Uceris (budesonide) extended-release tablets, 9 mg, in the U.S.
McKesson highlights power of community pharmacy in Vegas
McKesson ideaShare 2018, McKesson Corporation’s annual interactive forum for community pharmacists, kicked off today in Las Vegas. The annual event offers those in community pharmacy the opportunity to improve their knowledge, performance and profitability while networking with industry experts.
Technology can advance a 21st century regulatory process
Driven by the 21st Century Cures Act, Food and Drug Administration Commissioner Scott Gottlieb has publicly stated a goal of moving the FDA into the new century by creating a regulatory process that is modern and efficient.
Albertsons first chain pharmacy to practice new Idaho law
BOISE, Idaho – Albertsons Cos. announced this week their Idaho pharmacists can now prescribe for more health conditions under a new state law. Prior to the law’s July 1 effective date, targeted Albertsons Cos.
PCMA’s Merritt issues statement on drug pricing
Pharmaceutical Care Management Association (PCMA) president and chief executive officer Mark Merritt released the following statement on reports of yet another round of massive price hikes by drug manufacturers.
Catalent agrees to buy Juniper Pharmaceuticals
SOMERSET, N.J. – Catalent, a leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, announced that it has agreed to acquire Juniper Pharmaceuticals, including its Nottingham, U.K.-based Juniper Pharma Services division.
As Amazon enters market, patients, physicians hopeful for health care disruption
Amazon’s announced acquisition of PillPack gives the tech giant a vehicle for disrupting the U.S. drug distribution market – and may come with a beneficial side-effect for pharma. Amazon will find substantial reception for its Rx distribution services among U.S. patients and physicians.